The oncogenic BCR-ABL fusion protein disrupts ATR-dependent intra-S phase checkpoint in chronic myeloid leukemia after etoposide treatment, by causing DNA strand break formation [33]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.